NMRA
Neumora Therapeutics, Inc.Closed0.3545−0.02 −4.24%USD
NasdaqGS · as of Oct 14, 16:00 ET · 15m delayAfter hours 0.3700 +4.37%
Open
0.3900
Prev close
0.3702
Day range
0.31540.3983
52-week range
0.31543.65
Volume
2.80M2.32×
Mkt cap
66.61M
P/E ttm
—
Fwd P/E
-0.53
EPS ttm
-1.23
Div yield
0.00%
Earnings
Aug 14, 2026
From 52w high
−90.29%
NMRA earnings and estimates
NMRA Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 5
Before the open · estimated
EPS consensus
$−0.19
range −0.21 – −0.17
EPS growth vs year ago
+45.1%
year ago −0.35
Revenue consensus
$0
0.0% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±10.7%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 14, 2026 BMO | −0.23 | −0.24 | +5.34% | — | −7.5% | −12.4% |
| Mar '26 | May 7, 2026 BMO | −0.30 | −0.31 | +3.23% | $0 | −16.7% | −23.6% |
| Dec '25 | Mar 30, 2026 BMO | −0.35 | −0.33 | −7.01% | $0 | −17.2% | −9.0% |
| Sep '25 | Nov 6, 2025 BMO | −0.35 | −0.34 | −4.29% | $0 | −1.5% | +9.2% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.19 | −0.21−0.17 | +45.1% | $0 | 0.0% | −0.19 0.0% | −0.21 +7.4% | 4 / 2 |
| Next quarter Dec 2026 | −0.17 | −0.20−0.13 | +50.4% | $0 | 0.0% | −0.17 0.0% | −0.18 +6.1% | 4 / 2 |
| Current year Dec 2026 | −0.87 | −0.94−0.65 | +39.9% | $0 | 0.0% | −0.87 0.0% | −0.92 +5.3% | 5 / 2 |
| Next year Dec 2027 | −0.67 | −0.97−0.33 | +23.2% | $0 | 0.0% | −0.67 0.0% | −0.77 +13.5% | 5 / 2 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.19 | −0.20−0.17 | 4 | 0 / 0 |
| Dec 2026 | −0.16 | −0.18−0.13 | 4 | 0 / 0 |
| Mar 2027 | −0.14 | −0.18−0.10 | 3 | 0 / 0 |
| Jun 2027 | −0.15 | −0.18−0.10 | 3 | 0 / 0 |
| Sep 2027 | −0.17 | −0.20−0.11 | 3 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −0.83 | −0.90−0.65 | 4 | 0 / 0 |
| Dec 2027 | −0.69 | −0.97−0.33 | 4 | 0 / 0 |
| Dec 2028 | −0.60 | −0.96−0.32 | 3 | 0 / 0 |
| Dec 2029 | −0.33 | −0.860.20 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.